Literature DB >> 22730530

Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain.

Shunichiro Takezaki1, Masafumi Yamada, Masahiko Kato, Myoung-Ja Park, Kenichi Maruyama, Yasuhiro Yamazaki, Natsuko Chida, Osamu Ohara, Ichiro Kobayashi, Tadashi Ariga.   

Abstract

Chronic mucocutaneous candidiasis (CMC) is a heterogeneous group of primary immunodeficiency diseases characterized by chronic and recurrent Candida infections of the skin, nails, and oropharynx. Gain-of-function mutations in STAT1 were very recently shown to be responsible for autosomal-dominant or sporadic cases of CMC. The reported mutations have been exclusively localized in the coiled-coil domain, resulting in impaired dephosphorylation of STAT1. However, recent crystallographic analysis and direct mutagenesis experiments indicate that mutations affecting the DNA-binding domain of STAT1 could also lead to persistent phosphorylation of STAT1. To our knowledge, this study shows for the first time that a DNA-binding domain mutation of c.1153C>T in exon 14 (p.T385M) is the genetic cause of sporadic CMC in two unrelated Japanese patients. The underlying mechanisms involve a gain of STAT1 function due to impaired dephosphorylation as observed in the coiled-coil domain mutations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730530     DOI: 10.4049/jimmunol.1200926

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  IL-17 T cells' defective differentiation in vitro despite normal range ex vivo in chronic mucocutaneous candidiasis due to STAT1 mutation.

Authors:  Najla Mekki; Imen Ben-Mustapha; Luyan Liu; Lobna Boussofara; Satoshi Okada; Sophie Cypowyj; Najet Ghariani; Wafa Saidi; Mohamed Denguezli; Jean-Laurent Casanova; Anne Puel; Mohamed-Ridha Barbouche
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

Review 2.  A 1-year-old girl with a gain-of-function STAT1 mutation treated with hematopoietic stem cell transplantation.

Authors:  Juan Carlos Aldave; Enrique Cachay; Luis Núñez; Ausberto Chunga; Sergio Murillo; Sophie Cypowyj; Jacinta Bustamante; Anne Puel; Jean-Laurent Casanova; Armando Koo
Journal:  J Clin Immunol       Date:  2013-10-09       Impact factor: 8.317

Review 3.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

Review 4.  The mycobiota: interactions between commensal fungi and the host immune system.

Authors:  David M Underhill; Iliyan D Iliev
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

Review 5.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

6.  Phevor combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families.

Authors:  Marc V Singleton; Stephen L Guthery; Karl V Voelkerding; Karin Chen; Brett Kennedy; Rebecca L Margraf; Jacob Durtschi; Karen Eilbeck; Martin G Reese; Lynn B Jorde; Chad D Huff; Mark Yandell
Journal:  Am J Hum Genet       Date:  2014-04-03       Impact factor: 11.025

7.  Limitations of the 'ambush hypothesis' at the single-gene scale: what codon biases are to blame?

Authors:  Robert L Bertrand; Mona Abdel-Hameed; John L Sorensen
Journal:  Mol Genet Genomics       Date:  2014-10-12       Impact factor: 3.291

8.  Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis.

Authors:  Osamu Hirata; Satoshi Okada; Miyuki Tsumura; Reiko Kagawa; Mizuka Miki; Hiroshi Kawaguchi; Kazuhiro Nakamura; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Yoshihiro Takihara; Masao Kobayashi
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

9.  A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.

Authors:  Jakob Nielsen; Emil Kofod-Olsen; Eva Spaun; Carsten S Larsen; Mette Christiansen; Trine Hyrup Mogensen
Journal:  BMJ Case Rep       Date:  2015-10-22

10.  Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.

Authors:  Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.